Journal
APPLIED AND ENVIRONMENTAL MICROBIOLOGY
Volume 74, Issue 4, Pages 1076-1086Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AEM.01058-07
Keywords
-
Categories
Ask authors/readers for more resources
The production by filamentous fungi of therapeutic glycoproteins intended for use in mammals is held back by the inherent difference in protein N-glycosylation and by the inability of the fungal cell to modify proteins with mammalian glycosylation structures. Here, we report protein N-glycan engineering in two Aspergillus species. We functionally expressed in the fungal hosts heterologous chimeric fusion proteins containing different localization peptides and catalytic domains. This strategy allowed the isolation of a strain with a functional alpha-1,2-mannosidase producing increased amounts of N-glycans of the Man(5)GlcNAc(2) type. This strain was further engineered by the introduction of a functional GlcNAc transferase I construct yielding GlcNAcMan(5)GlcNac(2) N-glycans. Additionally, we deleted algC genes coding for an enzyme involved in an early step of the fungal glycosylation pathway yielding Man(3)GlcNAc(2) N-glycans. This modification of fungal glycosylation is a step toward the ability to produce humanized complex N-glycans on therapeutic proteins in filamentous fungi.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available